Work

Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials

Year: 2021

Type: review

Source: Therapeutic Innovation & Regulatory Science

DOI: 10.1007/s43441-021-00315-7

Authors: Chengxing Lu, Xiaoyun Li, Kristine Broglio, Paul Bycott, Qi Jiang, Xiaoming Li, Anna McGlothlin, Hong Tian, Jingjing Ye

Institutions: Biogen (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Atara Biotherapeutics (United States), AstraZeneca (United States), Pfizer (United States), Seagen (United States), Berry Consultants, LLC (United States)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

Open Access status: bronze

OpenAlex ID: W3175518030

FWCI: 1.811

Cites: 64

Cited by: 62

Related to: 10